Cargando…

METTL3 antagonizes 5-FU chemotherapy and confers drug resistance in colorectal carcinoma

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Li, Min, Xia, Mingyue, Zhang, Ziyu, Tan, Yanyin, Li, Enjie, Guo, Zhigang, Fang, Mingzhi, Zhu, Yong, Hu, Zhigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552725/ https://www.ncbi.nlm.nih.gov/pubmed/37503727 http://dx.doi.org/10.3892/ijo.2023.5549

Ejemplares similares

METTL3 antagonizes 5-FU chemotherapy and confers drug resistance in colorectal carcinoma
por: Li, Min, et al.
Publicado: (2022)

METTL3 promotes homologous recombination repair and modulates chemotherapeutic response in breast cancer by regulating the EGF/RAD51 axis
por: Li, Enjie, et al.
Publicado: (2022)

Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug-resistant human hepatocellular carcinoma cells to 5-FU
por: Tang, Bo, et al.
Publicado: (2018)

NDRG4 sensitizes CRC cells to 5-FU by upregulating DDIT3 expression
por: Li, Ruikai, et al.
Publicado: (2022)

Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells
por: He, Lingfeng, et al.
Publicado: (2018)

FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
por: He, Lingfeng, et al.
Publicado: (2017)

Corrigendum to “The novel putative methyltransferase METTL7A as one prognostic biomarker potentially associated with immune infiltration in human renal cancer”
por: Yang, Zhiqian, et al.
Publicado: (2023)

MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer
por: Zhang, Y, et al.
Publicado: (2015)

MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer
por: Zhang, Y, et al.
Publicado: (2016)

Corrigendum to “Study on the Therapeutic Benefit on Lactoferrin in Patients with Colorectal Cancer Receiving Chemotherapy”
por: Moastafa, Tarek M., et al.
Publicado: (2015)

[Corrigendum] METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression
por: Zhang, Yongxi, et al.
Publicado: (2023)

In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs
por: Ashley, D M, et al.
Publicado: (2009)

Inhibition of O-GlcNAc transferase sensitizes prostate cancer cells to docetaxel
por: Xia, Mingyue, et al.
Publicado: (2022)

Corrigendum: Inhibition of O-GlcNAc transferase sensitizes prostate cancer cells to docetaxel
por: Xia, Mingyue, et al.
Publicado: (2023)

Polη, Polζ and Rev1 together are required for G to T transversion mutations induced by the (+)- and (−)-trans-anti-BPDE-N(2)-dG DNA adducts in yeast cells
por: Zhao, Bo, et al.
Publicado: (2006)

Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy
por: Paré, L, et al.
Publicado: (2009)

Corrigendum to “Effects of alternate-day fasting, time-restricted fasting and intermittent energy restriction DSS-induced on colitis and behavioral disorders” [Redox Biology 32, 2020, 101535]
por: Zhang, Xin, et al.
Publicado: (2021)

Chemotherapy of Pneumonias
Publicado: (1979)

Silencing of RIPK4 inhibits epithelial-mesenchymal transition by inactivating the Wnt/β-catenin signaling pathway in osteosarcoma
por: Yi, Zhigang, et al.
Publicado: (2022)

Corrigendum to “Determination of Hardness and Fracture Toughness of Y-TZP Manufactured by Digital Light Processing through the Indentation Technique”
por: Mei, Ziyu, et al.
Publicado: (2021)

ShenQi FuZheng Injection combined with chemotherapy in the treatment of colorectal cancer: A meta-analysis
por: Xu, Rongzhong, et al.
Publicado: (2017)

Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
por: Ye, Liping, et al.
Publicado: (2022)

Corrigendum to “Effects of Shenfu Injection in the Treatment of Septic Shock Patients: A Multicenter, Controlled, Randomized, Open-Label Trial”
por: Li, Yi, et al.
Publicado: (2016)

Weighted gene co-expression network analysis of colorectal cancer liver metastasis genome sequencing data and screening of anti-metastasis drugs
por: Gao, Bo, et al.
Publicado: (2016)

Translational Science 22 conference proceedings – CORRIGENDUM
por: Pliakos, Elina E., et al.
Publicado: (2023)

Small-molecule inhibition of APE1 induces apoptosis, pyroptosis, and necroptosis in non-small cell lung cancer
por: Long, Kaili, et al.
Publicado: (2021)

Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy
por: Mangala, Lingegowda S., et al.
Publicado: (2021)

Characteristics of myeloid sarcoma in mice and patients with TET2 deficiency
por: Wang, Jinhuan, et al.
Publicado: (2020)

5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs
por: Miura, Koh, et al.
Publicado: (2010)

CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis
por: Lai, Qiuhua, et al.
Publicado: (2020)

METTL1 gene polymorphisms synergistically confer hepatoblastoma susceptibility
por: Ge, Lili, et al.
Publicado: (2022)

Corrigendum to “Sodium Fluorescein-Guided Resection under the YELLOW 560 nm Surgical Microscope Filter in Malignant Gliomas: Our First 38 Cases Experience”
por: Zhang, Ningning, et al.
Publicado: (2018)

Corrigendum to “XRRA1 Targets ATM/CHK1/2-Mediated DNA Repair in Colorectal Cancer”
por: Wang, Wenjun, et al.
Publicado: (2021)

Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia [Corrigendum]
Publicado: (2015)

Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy: A Single-Institution Experience [Corrigendum]
Publicado: (2020)

Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas
por: Bain, G H, et al.
Publicado: (2015)

Expression and clinical significance of METTL3 in colorectal cancer
por: Li, Hui, et al.
Publicado: (2023)

ECM1 regulates the resistance of colorectal cancer to 5-FU treatment by modulating apoptotic cell death and epithelial-mesenchymal transition induction
por: Long, Sirui, et al.
Publicado: (2022)

Corrigendum to “Formononetin Administration Ameliorates Dextran Sulfate Sodium-Induced Acute Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway”
por: Wu, Dacheng, et al.
Publicado: (2018)

Targeting FAPα-expressing hepatic stellate cells overcomes resistance to antiangiogenics in colorectal cancer liver metastasis models
por: Qi, Ming, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rlqgl712nev0ephcieirg7lub3